Chiara Pirillo

Postdoctoral Scholar, Hematology-Oncology

Honors & Awards

New Investigator Award, International Society for experimental hematology (2022)
Blood Cancer uk Gordon Piller Studentship, Blood Cancer UK (Bloodwise) (2016-2020)
Abstract selected for the British Society of Immunology Congress, British Society of Immunology (2023)
Best poster presentation prize for the British Society of Imunology-Scottish Immunology Group, British Society of Immunology (2023)
Abstract selected for the 61st American Society of Hematology meeting and Exposition, American Society of Hematology (2019)

Boards, Advisory Committees, Professional Organizations

Member, British Society of Immunology, British Society of Immunology (2020 - Present)
Member, European Hematology Association (EHA), European Hematology Association (2024 - Present)
Member, International society of experimental hematology (ISEH), International Society of experimental hematology (2016 - Present)
Member, American Society of Hematology (ASH), American Society of Hematology (2019 - Present)

Professional Education

Master of Science, Universita Degli Studi Di Pisa (2016)
Bachelor of Science, Universita Degli Studi Di Pisa (2013)
Doctor of Philosophy, Imperial College of London (2021)
PhD, Imperial College, London, Hematology (2020)
MSc, University of Pisa, Biomedical Sciences (2016)
BSc, University of Pisa, Molecular Biology (2013)

All Publications

Profiles With Related Publications

close
Varuna Chander

Postdoctoral Scholar, Genetics Temp - Non-Exempt, Office of Technology Licensing (OTL)

11 Total Publications
close
Joonseok Cho

Basic Life Research Scientist, Medicine - Med/Endocrinology

14 Total Publications
close
Agnieszka Czechowicz, MD, PhD

Assistant Professor of Pediatrics (Stem Cell Transplantation)
Research Interests
Dr. Czechowicz’s research is aimed at understanding how hematopoietic stem cells interact with their microenvironment in order to subsequently modulate these interactions to improve bone marrow transplantation and unlock biological secrets that further enable regenerative medicine broadly. This work can be applied across a variety of disease states ranging from rare genetic diseases, autoimmune diseases, solid organ transplantation, microbiome-augmentation and cancer.

64 Total Publications
close
Edgar Engleman

Professor of Pathology and of Medicine (Immunology and Rheumatology)
Research Interests
Dendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.

291 Total Publications
close
C. Garrison Fathman

Professor of Medicine (Immunology and Rheumatology), Emeritus
Research Interests
My lab of molecular and cellular immunology is interested in research in the general field of T cell activation and autoimmunity. We have identified and characterized a gene (GRAIL) that seems to control regulatory T cell (Treg) responsiveness by inhibiting the Treg IL-2 receptor desensitization. We have characterized a gene (Deaf1) that plays a major role in peripheral tolerance in T1D. Using PBC gene expression, we have provisionally identified a signature of risk and progression in T1D.

326 Total Publications
close
Peter Greenberg

Professor of Medicine (Hematology), Emeritus
Clinical Focus
Cancer > Hematology, Hematology, Myelodysplastic Syndromes

345 Total Publications
close
Aanchal Preet Kaur

Postdoctoral Scholar, Hematology-Oncology

4 Total Publications
close
Bayan Kharrat

Postdoctoral Scholar, Developmental Biology

3 Total Publications
close
Thomas Koehnke

Senior Research Scientist-Basic Life, Stem Cell Bio Regenerative Med Institute

50 Total Publications
close
Lea Lemaitre

Postdoctoral Scholar, Gastroenterology

9 Total Publications
close
Kyle Loh

Assistant Professor of Developmental Biology (Stem Cell)

60 Total Publications
close
Ravi Majeti MD, PhD

Director, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Virginia and D. K. Ludwig Professor and Professor of Medicine (Hematology/Stem Cell Institute)
Research Interests
The Majeti lab focuses on the molecular/genomic characterization and therapeutic targeting of leukemia stem cells in human hematologic malignancies, particularly acute myeloid leukemia (AML). Our lab uses experimental hematology methods, stem cell assays, genome editing, and bioinformatics to define and investigate drivers of leukemia stem cell behavior. As part of these studies, we have led the development and application of robust xenotransplantation assays for human hematopoietic cells.

195 Total Publications